Navigation Links
Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Date:4/28/2008

RALEIGH, N.C., April 28 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Doug Linton has joined its Executive Advisory Group. The group is made up of industry professionals brought together by Campbell Alliance CEO John Campbell to bring special expertise to highly complex engagements. Mr. Linton will focus on distribution-related issues, working closely with Campbell Alliance's Trade and Distribution Practice.

Mr. Linton started with Cardinal Health, a global manufacturer and distributor of medical and surgical supplies and technologies, in 1981, and he has worked in the pharmaceutical distribution field for more than 20 years. At Cardinal, he played a key role developing the sophisticated investment buying program and central purchasing system that powered the firm's consolidation strategy, which transformed it from a small regional player in the early 1980s to a highly profitable national drug wholesaler by the mid- 1990s. Mr. Linton also developed and was president of several very profitable new business units for Cardinal, including National PharmPak Services, a re- packaging company, and National Specialty Services, which focused on distribution of plasma and oncology products. Mr. Linton reported to the founder and CEO of Cardinal Health during a majority of his tenure and was a member of senior management.

After leaving Cardinal in 1995, Mr. Linton worked as a senior executive with two regional drug wholesalers to develop purchasing capabilities similar to those he established at Cardinal. He then returned to Cardinal as a consultant to develop an analytical fee-for-service program for smaller manufacturers, and he directed its implementation with more than 60 manufacturers in less than twelve months. Today that program is used with close to 200 manufacturers.

After leaving Cardinal two years ago, Mr. Linton consulted to over 20
'/>"/>

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...onal carbon layer in which the carbon atoms are ar...omb. Carbon nanotubes are rolled-up sheets of grap...hite. Graphene boasts some very special characteri...t thermal conductor, and reconciles such conflicti...tion, graphene is impermeable to gases, which make...
(Date:11/23/2009)...wire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;T...dentifiesandadvancesadiverseportfolioofpromisingca...odayreportedthatCytopia(ASX:CYT)hascommencedenroll...ly-administeredJAK1/JAK2inhibitor.Thetrialisbeingc...ltomergeCytopiaintoYMhasbeenpreviouslyannouncedand...
(Date:11/23/2009)...uo;s Sporicidin disinfectant solution and wipes ar...nts against H1N1 and Influenza A., , ...009 -- Contec Inc, the leading manufacturer of cl...icidin disinfectants have been deemed by the EPA ...uding Pandemic 2009 H1N1 influenza A virus (the sw...
(Date:11/23/2009).../-InimexPharmaceuticals,Inc.announcedtodaythatitha.... ,, Abramsbringsmorethan25yearsofdrugdiscovery...fthenuclearmedicineimagingagent,Cardiolite,andwork...ger,BiomedicalResearchWorldwide.In1996,Abramsledth...andCEOfrom1996to2006.AnorMEDdiscoveredanddeveloped...
Breaking Biology Technology:Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2
...OKYO, Japan, April 28 HOYA Corporation today,anno...n for the period,ended March 31, 2008, a 36.5% inc...rating income for the quarter was 18.0 billion yen...in the prior year period. Net,income for the fourt...are,were 37.71 yen. For the same quarter of the pr...
... Vaccine for new strain of virus broadens governme... France, April 28 ,Sanofi Pasteur, the vaccines di...at the U.S. Department of Health and Human Service...produce approximately 38.5 million,doses of vaccin...za. Sanofi,Pasteur has a multi- year contract with...
...ANJING, CHINA, April 28 Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals and manufa... Endu in China, today announced that it has been,i... Good Management,Limited, a British Virgin Islands...luding certain senior management of Simcere Pharma...
Other Biology Technology:Hoya Announces Fourth Quarter and FY2007 Financial Results 2Hoya Announces Fourth Quarter and FY2007 Financial Results 3U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 2U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 3U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 4Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 3
(Date:11/23/2009)...controvertible evidence" that the volcanic super-e...000 years ago deforested much of central India, so...ort. , The volcano ejected an estimated 800 cubi... crater (now the world,s largest volcanic lake) th...Ash from the event has been found in India, the In...
(Date:11/23/2009)...sity of Alabama at Birmingham (UAB) researchers sh...ical conditions (co-morbidity) do not explain the ...s compared to Caucasians who also have colon cance...r , a journal of the American Cancer Society. , ...bidity are independent predictors of poor survival...
(Date:11/23/2009)...ries about the multiple health benefits of vitamin...ient, increased awareness of the huge numbers of p...d even led to an appreciation of it as "nature,s a...of your immune system to prevention of heart disea...is now seen as one of the most critical nutrients ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Par Pharmaceutical Receives Final Approval To Market Generic Starlix 28R 29 56816 1Par Pharmaceutical Receives Final Approval To Market Generic Starlix 28R 29 56816 2SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 1SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 2SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 3FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 13986 1FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 13986 2
...al Center have identified a previously unknown fam...esponsible for the plague especially efficient at ...nly demonstrated that the use of the common roundw... Yersinia pestis, the bacterium that causes plague... pestis and the worm is quite similar to what occu...
...ege are using tobacco plants to produce monoclonal...t can target and hunt down cancer cells. The plant...roducing anticancer antibodies, raising hopes that...cientists, led by Hilary Koprowski, M.D., professo...he Biotechnology Foundation Laboratories and the C...
...have made significant new advances in determining ...covery that in one sense takes up where Watson and...e-helical structure of this biological blueprint f...hemistry is to predict the structure of a molecule...he "Holy Grail" of protein chemistry. , Today, th...
Other Biology News:Novel plague virulence factor identified 2Novel plague virulence factor identified 3Novel plague virulence factor identified 4Scientists turn tobacco against cancer 2Major advance made on DNA structure 2Major advance made on DNA structure 3
21-mer duplex from B-Bridge International
...s the first fully genetically encoded fluorescent ...acellular hydrogen peroxide (H2O2), one of the mai...f yellow fluorescent protein inserted into the reg...xyR-RD), HyPer demonstrates submicromolar affinity...
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: